U.S. health insurance firm Humana is the only major stock from around the world to have risen by more than 10% every year for the past decade. Here's what some are saying: Deutsche Bank Equity analyst George Hill bumped up the bank's price target to $568 (10% upside) on April 26. RBC Capital Markets Ben Hendrix retired the bank's outperform rating and price target of $637 on April 27. The investment bank maintains an "in-line" or hold rating on the stock with a price target of $637. Jefferies' analysts raised their price target to $614 with a buy-rating on April 27.

---

Persons: —, Humana's, George Hill, JP Morgan Lisa Gill, HUM, UBS Kevin Caliendo, Ben Hendrix, Morgan Stanley's, Jefferies Organizations: Humana, CNBC Pro, Affordable, NYSE, Deutsche Bank Equity, MLR, UBS, Swiss, Medicare, RBC Locations: Kentucky, U.S